RGS18 Antibodies

Santa Cruz Biotechnology features a diverse variety of RGS18 monoclonal antibodies for research focused on understanding RGS18's role in cellular signaling pathways. RGS18 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RGS18, or Regulator of G-protein Signaling 18, plays a crucial role in modulating G-protein signaling, which is essential for various physiological processes, including immune response and cell proliferation. By regulating the activity of G-proteins, RGS18 influences signal transduction pathways that are vital for maintaining cellular homeostasis and responding to external stimuli. Understanding RGS18 function can provide insights into its potential implications in diseases and therapeutic targets. Researchers can explore G-protein signaling pathways using specific detection methods such as western blotting (WB) to analyze protein expression levels, or immunofluorescence (IF) to visualize protein localization within cells. Flow cytometry (FCM) enables quantitative analysis of RGS18 expression in different cell populations, while immunoprecipitation (IP) helps study protein-protein interactions. Enzyme-linked immunosorbent assay (ELISA) provides sensitive detection of RGS18 in various sample types. Santa Cruz Biotechnology monoclonal antibodies for RGS18 research support scientists worldwide in advancing our understanding of cellular signaling mechanisms and potential therapeutic applications.